Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 4295029, 7 pages
http://dx.doi.org/10.1155/2016/4295029
Research Article

D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival

1Department of General Surgery, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey
2Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey

Received 30 January 2016; Accepted 1 August 2016

Academic Editor: Tetsuro Setoyama

Copyright © 2016 Kemal Tekeşin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Folkman, “What is the evidence that tumors are angiogenesis dependent?” Journal of the National Cancer Institute, vol. 82, no. 1, pp. 4–6, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Weidner, J. P. Semple, W. R. Welch, and J. Folkman, “Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma,” The New England Journal of Medicine, vol. 324, no. 1, pp. 1–8, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Folkman, P. Cole, and S. Zimmerman, “Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment,” Annals of Surgery, vol. 164, no. 3, pp. 491–502, 1966. View at Publisher · View at Google Scholar · View at Scopus
  4. I. F. Tannock, “Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor,” Cancer Research, vol. 30, no. 10, pp. 2470–2476, 1970. View at Google Scholar · View at Scopus
  5. D. Shweiki, A. Itin, D. Soffer, and E. Keshet, “Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis,” Nature, vol. 359, no. 6398, pp. 843–845, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. W. D. Thompson, K. J. Shiach, R. A. Fraser, L. C. McIntosh, and J. G. Simpson, “Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth,” The Journal of Pathology, vol. 151, no. 4, pp. 323–332, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ziche and P. M. Gullino, “Angiogenesis and neoplastic progression in vitro,” Journal of the National Cancer Institute, vol. 69, no. 2, pp. 483–487, 1982. View at Google Scholar · View at Scopus
  8. C. H. Blood and B. R. Zetter, “Tumor interactions with the vasculature: angiogenesis and tumor metastasis,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 1032, no. 1, pp. 89–118, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Buccheri, D. Ferrigno, C. Ginardi, and C. Zuliani, “Haemostatic abnormalities in lung cancer: prognostic implications,” European Journal of Cancer, vol. 33, no. 1, pp. 50–55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Z. Wojtukiewicz, L. R. Zacharski, V. A. Memoli et al., “Indirect activation of blood coagulation in colon cancer,” Thrombosis and Haemostasis, vol. 62, no. 4, pp. 1062–1066, 1989. View at Google Scholar · View at Scopus
  11. R. Dover, N. L. M. Goeting, I. Taylor, O. S. Roath, and J. L. Francis, “Factor X-activating activity in patients with colorectal carcinoma,” British Journal of Surgery, vol. 74, no. 12, pp. 1122–1124, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. G. F. Pineo, E. Regoeczi, M. W. C. Hatton, and M. C. Brain, “The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas,” Journal of Laboratory and Clinical Medicine, vol. 82, no. 2, pp. 255–266, 1973. View at Google Scholar · View at Scopus
  13. S. J. Kempin, “Hemostatic defects in cancer patients,” Cancer Investigation, vol. 15, no. 1, pp. 23–36, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Y. Lip, B. S. Chin, and A. D. Blann, “Cancer and the prothrombotic state,” The Lancet Oncology, vol. 3, no. 1, pp. 27–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Gouin-Thibault and M. M. Samama, “Laboratory diagnosis of the thrombophilic state in cancer patients,” Seminars in Thrombosis and Hemostasis, vol. 25, no. 2, pp. 167–172, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. H. M. W. Verheul, K. Hoekman, F. Lupu et al., “Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas,” Clinical Cancer Research, vol. 6, no. 1, pp. 166–171, 2000. View at Google Scholar · View at Scopus
  17. D. L. Cooper, A. B. Sandler, L. D. Wilson, and T. P. Duffy, “Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer: response to epsilon-aminocaproic acid,” Cancer, vol. 70, no. 3, pp. 656–658, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. R. W. F. Geenen, K. P. J. Delaere, and J. W. J. Van Wersch, “Coagulation and fibrinolysis activation markers in prostatic carcinoma patients,” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 35, no. 2, pp. 69–72, 1997. View at Google Scholar · View at Scopus
  19. M. Z. Wojtukiewicz, L. R. Zacharski, T. E. Moritz, K. Hur, R. L. Edwards, and F. R. Rickles, “Prognostic significance of blood coagulation tests in carcinoma of the lung and colon,” Blood Coagulation and Fibrinolysis, vol. 3, no. 4, pp. 429–437, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. van Duijnhoven, F. A. T. Lustermans, and J. W. J. Van Wersch, “Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer,” Haemostasis, vol. 23, no. 3, pp. 168–172, 1993. View at Google Scholar · View at Scopus
  21. E. C. Gabazza, O. Taguchi, T. Yamakami, M. Machishi, H. Ibata, and S. Suzuki, “Evaluating prethrombotic state in lung cancer using molecular markers,” Chest, vol. 103, no. 1, pp. 196–200, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Taguchi, E. C. Gabazza, H. Yasui, T. Kobayashi, M. Yoshida, and H. Kobayashi, “Prognostic significance of plasma D-dimer levels in patients with lung cancer,” Thorax, vol. 52, no. 6, pp. 563–565, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Gadducci, U. Baicchi, R. Marrai et al., “Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand Factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status,” Gynecologic Oncology, vol. 49, no. 3, pp. 354–358, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. G.-F. von Tempelhoff, M. Dietrich, F. Niemann, D. Schneider, G. Hommel, and L. Heilmann, “Blood coagulation and thrombosis in patients with ovarian malignancy,” Thrombosis and Haemostasis, vol. 77, no. 3, pp. 456–461, 1997. View at Google Scholar · View at Scopus
  25. C. Rella, M. Coviello, N. De Frenza et al., “Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125,” Tumori, vol. 79, no. 5, pp. 347–351, 1993. View at Google Scholar · View at Scopus
  26. K. Blackwell, Z. Haroon, G. Broadwater et al., “Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status,” Journal of Clinical Oncology, vol. 18, no. 3, pp. 600–608, 2000. View at Google Scholar · View at Scopus
  27. M. Oya, Y. Akiyama, T. Yanagida, S. Akao, and H. Ishikawa, “Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker,” Surgery Today, vol. 28, no. 4, pp. 373–378, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. H. J. Wanebo, B. Rao, C. M. Pinsky et al., “Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer,” The New England Journal of Medicine, vol. 299, no. 9, pp. 448–451, 1978. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Goslin, G. Steele Jr., J. MacIntyre et al., “The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers,” Annals of Surgery, vol. 192, no. 6, pp. 747–751, 1980. View at Publisher · View at Google Scholar · View at Scopus
  30. C. G. Moertel, J. R. O'Fallon, V. L. W. Go, M. J. O'Connell, and G. S. Thynne, “The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer,” Cancer, vol. 58, no. 3, pp. 603–610, 1986. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Blackwell, H. Hurwitz, G. Liebérman et al., “Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma,” Cancer, vol. 101, no. 1, pp. 77–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kilic, O. Yoldas, M. Keskek et al., “Prognostic value of plasma D-dimer levels in patients with colorectal cancer,” Colorectal Disease, vol. 10, no. 3, pp. 238–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Oya, Y. Akiyama, T. Okuyama, and H. Ishikawa, “High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer,” Japanese Journal of Clinical Oncology, vol. 31, no. 8, pp. 388–394, 2001. View at Google Scholar